IP Library Granted Patent US 7,875,299
Granted Patent B2
US 7,875,299 · App. 10/834,162 · Granted Jan 25, 2011

Compositions and methods for enhancing or treating female sexual response

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,299
App. No.
10/834,162
Granted
Jan 25, 2011
Kind
B2
Abstract

The present invention relates to compositions, articles of manufacture, methods of preparation thereof, methods of use thereof, etc., for enhancement of sexual pleasure, conditions, disorders, and diseases related to reproductive physiology and systems, especially of mammalian females. For instance, the present invention relates to all aspects of modulating the female sexual response, including female sexual dysfunction, such as female sexual arousal disorders (FSAD), orgasmic disorders, and sexual pain disorders, and enhancing female sexual pleasure and satisfaction of the female sexual experience. Accordingly, the present invention relates to compositions comprising botanical extracts, active agents, etc., which are useful to treat or affect any of the aforementioned conditions. For example, the present invention relates to a composition, preferably for topical or local use, which comprises one or more of the following ingredients, including, but not limited to, borage seed oil, Angelica pubescens root and other angelica species, Coleus forskohlii extract, vinpocetine, ferulic acid, magnesium, ascorbyl palmitate, capric/caprylic triglyceride, silica, and equivalents thereof.

Claims (13)

1. A method for improving female sexual arousal, treating female sexual arousal disorder, female orgasmic disorder, or female sexual pain disorder comprising:

applying to the external female genitalia or vagina of a female in need thereof, a composition comprising:

a therapeutically effective amount of gamma linolenic acid, a therapeutically effective amount of Angelica root, and a therapeutically effective amount of Coleus forskohlii extract.

2. The method of claim 1 , wherein the gamma linolenic acid comprises 10% to 99% w/w of said composition.

3. The method of claim 1 , wherein the gamma linolenic acid is from borage seed oil.

4. The method of claim 1 , wherein the Angelica root comprises 0.001% to 99% w/w of the composition.

5. The method of claim 1 , wherein the Angelica root is Angelica pubescens.

6. The method of claim 1 , wherein the Coleus forskohlii comprises 0.001 to 8% w/w of the composition.

7. The method of claim 1 , wherein the composition further comprises vinpocetine.

8. The method of claim 7 , wherein the composition comprises 0.001% to 8% w/w vinpocetine.

9. The method of claim 1 , wherein the composition further comprises a flavoring agent.

10. The method of claim 9 , wherein the flavoring agent is a sweetening agent.

11. The method of claim 9 , wherein the flavoring agent is selected from the group consisting of saccharin, monosodium guanosine mono phosphate, blackberry and lavender.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 14, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: SEMPRAE LABORATORIES, INC.
Reel/Frame 067728/0411 →
SECURITY INTEREST Recorded Feb 10, 2022
From: SEMPRAE LABORATORIES, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 058976/0822 →
RELEASE OF SECURITY INTEREST Recorded Jan 28, 2022
From: NJEDA; NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY
To: SEMPRAE LABORATORIES, INC.
Reel/Frame 058815/0437 →
SECURITY INTEREST Recorded Jan 27, 2022
From: INNOVUS PHARMACEUTICALS, INC.; SEMPRAE LABORATORIES, INC.
To: ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), AS AGENT
Reel/Frame 058789/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2020
From: CROSBY, MARTIN G.; BENNETT, ROBERT M.
To: QUALILIFE
Reel/Frame 053950/0093 →
SECURITY AGREEMENT Recorded Sep 7, 2012
From: SEMPRAE LABORATORIES, INC.
To: NJEDA
Reel/Frame 028992/0604 →